Is a complete POM research report available?

No complete published report is available for Pomdoctor Limited (POM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pomdoctor Limited (POM)

NASDAQ: POM · USD

$0.58

-0.12 (-17.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first POM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4.3M
Revenue (ttm)	57.2M
Net income (ttm)	-30.4M
EPS (ttm)	-$9.42
Shares out	7.5M
Volume	194,586

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.2M
Net income (ttm): -30.4M
EPS (ttm): -$9.42
Market cap: 4.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All POM indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

CNY

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001877971
Company name	Pomdoctor Limited
Country	China
Country code	US
Cusip	73181R207
Employees	165
Employees Change	9%
Employees Change Percent	5.77
Enterprise value	$68.3M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Pharmaceutical Retailers
IPO Date	2025-10-08
Isin	US73181R2076
Last refreshed	2026-07-31
Market cap	$4.3M
Market cap category	Nano-Cap
Price	$0.58
Price currency	USD
Rev Per Employee	346,523.94x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	5900
Symbol	POM
Website	https://www.7lk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-652.27%
EV/Sales	1.2x
FCF yield	-476.55%
P/S ratio	0.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-29.67%
EBITDA Margin	-29.63%
Gross margin	13.07%
Gross Profit	$7.5M
Gross Profit Growth	9.62%
Gross Profit Growth Q	25.11%
Gross Profit Growth3 Y	-1.59%
Net Income	$-30.4M
Net Income Growth Years	0%
Pretax Margin	-53.16%
Profit Margin	-53.16%
Profit Per Employee	$-184,199
ROA	-94.72
Roa5y	-44.13
ROCE	111

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	2
Revenue Growth	16.74x
Revenue Growth Q	17.18x
Revenue Growth Years	2x
Revenue Growth3 Y	17.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$5.2
Assets	$15.4M
Cash	$1.4M
Current Assets	$15.5M
Current Liabilities	$32.3M
Debt	$65M
Equity	$-68.8M
Interest Coverage	-9.53
Liabilities	$84.2M
Long Term Assets	$-151,796
Long Term Liabilities	$51.9M
Net Cash	$-63.7M
Net Cash By Market Cap	$-1,367
Tangible Book Value	$-64.9M
Tangible Book Value Per Share	$-8.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.48
Inventory Turnover	39.85
Net Working Capital	$-5.5M
Quick ratio	0.14
Working Capital	$-16.2M
Working Capital Turnover	$-0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-53.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	20.93
50-day SMA	1.53
50-day SMA vs 200-day SMA	50under200
All Time High	115.7
All Time High Change	-99.5%
All Time High Date	2025-11-06
All Time Low	0.5
All Time Low Change	15.6%
All Time Low Date	2026-07-30
ATR	0.23
Beta1y	0.9
Ch YTD	-89.11
High	0.75
High52	115.7
High52 Date	2025-11-06
High52ch	-99.5%
Low	0.5
Low52	0.5
Low52 Date	2026-07-30
Low52ch	15.6%
Ma50ch	-62.22%
Premarket Change Percent	-5.2
Premarket Price	$0.66
Premarket Volume	18,216
Price vs 200-day SMA	-97.24%
RSI	26.98
RSI Monthly	0
RSI Weekly	30.67
Sharpe ratio	-0.57x
Sortino ratio	-0.77
Total Return	-53.41%
Tr YTD	-89.11
Tr1m	-60.95%
Tr1w	-19.06%
Tr3m	-91.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-16.7M
Operating margin	-29.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,457,784%
Float Percent	46.38%
Net Borrowing	2,079,776.5
Shares Insiders	19.27%
Shares Institutions	0.63%
Shares Out	7,455,253
Shares Qo Q	106.82%
Shares Yo Y	53.41%
Short Ratio	0.42
Short Shares	0.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.6M
Adjusted OCF	-24,396,871.7
Average Volume	59,838.65x
Bv Per Share	-8.4
CAPEX	$-237,861
Ch1m	-60.95
Ch1w	-19.06
Ch3m	-91.36
Ch6m	-85.48
Change	-17.51%
Change From Open	-20.32
Close	0.7
Days Gap	3.53
Depreciation Amortization	22,089.4
Dollar Volume	112,470.7
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-17.6M
EBITDA	$-17.5M
EPS	$-9.42
F Score	2
FCF	$-22.2M
FCF EV Yield	-32.5x
FCF Per Share	$-2.98
Financing CF	22,007,136
Fiscal Year End	December
Founded	2,015
Income Tax	$54
Investing CF	-229,863
Ipr	-84.38
Iprfo	-99.23
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2025-12-31
Last Split Date	2026-06-22
Last Split Type	Reverse
Last10k Filing Date	2026-05-14
Ma150	4.07
Ma150ch	-85.81%
Ma20	1.14
Ma20ch	-49.16%
Net CF	275,745
Next Earnings Date	2026-11-03
Open	0.73
Optionable	No
Position In Range	31.53
Post Close	0.58
Postmarket Change Percent	-8.3
Postmarket Price	$0.53
Ppne	184,425.4
Pre Close	0.7
Price Date	2026-07-30
Relative Volume	3.25x
Revenue	57,176,450x
SBC By Revenue	4.11x
Share Based Comp	2,348,119
Tax By Revenue	0x
Tr6m	-85.48%
Volume	194,586
Z Score	-30.24

Pomdoctor Limited (POM)

Coverage state: Market snapshot only — no published research

Generate the first POM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · POM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All POM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on POM

Frequently asked questions